Evaluation of Buspirone on Streptozotocin Induced Type 1 Diabetes and Its Associated Complications
We have evaluated the effect of buspirone (1.5 mg/kg/day, p.o.) type 1 diabetes induced cardiovascular complications induced by streptozotocin (STZ, 45 mg/kg, i.v.) in Wistar rats. Various biochemical, cardiovascular, and hemodynamic parameters were measured at the end of 8 weeks of treatment. STZ p...
Main Authors: | Suchi Raghunathan, Pratik Tank, Shraddha Bhadada, Bhoomika Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/948427 |
Similar Items
-
Buspirone in ADHD
by: J Gordon Millichap
Published: (1998-04-01) -
Catechin Treatment Ameliorates Diabetes and Its Complications in Streptozotocin-Induced Diabetic Rats
by: Saeed Samarghandian, et al.
Published: (2017-02-01) -
Buspirone-associated Movement Disorder: A Literature Review
by: Jamir Pitton Rissardo, et al.
Published: (2020-03-01) -
Paroxetine-induced severe sleep bruxism successfully treated with buspirone
by: Aysel Milanlıoglu
Published: (2012-01-01) -
The Effect of Chronic Administration of Buspirone on 6-Hydroxydopamine-Induced Catalepsy in Rats
by: Hamdolah Sharifi, et al.
Published: (2012-06-01)